Navigating the Regulatory and Manufacturing Realities of mRNA Therapeutic Development

The rapidly evolving mRNA therapeutics landscape is prompting new regulatory and manufacturing challenges. Industry experts will discuss these in a GEN webinar, covering subjects like manufacturing options, process considerations, automation, digital tools, and facility design. They will also address how equipment and technology impact efficiency and scalability in mRNA manufacturing, important regulatory considerations, and how Cytiva’s suite of solutions aids drug developers in their mRNA projects.